Saturday 14 November 2026 Daily emailMarket analysisEnterpriseVigiEye regulatory newsCompePharma CRM & HR →
The business of pharma
Financing

Mingteng International, an automotive mold maker, prices $2.00/share registered direct offering with pre-funded warrants

Mingteng International Corporation, a Cayman holding company making automotive casting molds in Wuxi, China, disclosed in its six-month period report to June 30, 2026 a June 9, 2026 registered direct offering. It agreed to sell 501,834 Class A shares at $2.00 each, plus pre-funded warrants for up to 629,170 shares, to institutional investors. The company also reported shareholder approval on May 29, 2026 of higher Class B voting rights and a par value reduction. It is not a pharma or biotech business.

13 Nov 2026 · Mingteng International Corp Inc. MTEN · Company news

Company's press release (SEC filing): Mingteng International Corp Inc. ↗

Written by CompePharma's editorial system from the company's filing; claims are the company's. AI-assisted; check the source before acting. Not investment advice.

More FinancingAll →